🇺🇸 FDA
Patent

US 11938182

Halogenated xanthenes as vaccine adjuvants

granted A61KA61K2039/55511A61K39/0011

Quick answer

US patent 11938182 (Halogenated xanthenes as vaccine adjuvants) held by Provectus Pharmatech, Inc. expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Provectus Pharmatech, Inc.
Grant date
Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/55511, A61K39/0011, A61K39/39